Our Mission Statement
Enabling biotechnology professionals, innovations, and solutions by being the “go-to” global resource for information exchange and dialogue across academia, Industry, and government
Meet our Executive Committee
Chair: John (Yonghyun) Kim
Associate Professor of Chemical & Biological Engineering at University of Alabama
Previous Chair: Michelle O’Malley
Professor of Chemical Engineering at University of California, Santa Barbara
Chair-elect: Aaron Noyes
Senior Vice President, Apogee Therapeutics
Treasurer: Venkatesh Natarajan
Principal Engineer, Amgen
Secretary: Elizabeth Goodrich
R&D Technical Director at MilliporeSigma
Long Range Program Chair: Mark Blenner
Thomas and Kipp Gutshall Career Development Professor of Chemical and Biomolecular Engineering at University of Delaware
Awards Chair: Brian Pfleger
Karen and William Monfre Professor of Chemical Engineering at University of Wisconsin-Madison
Councilor: Varnika Roy
Senior Director, Manufacturing Science & Technology at GlaxoSmithKline
Term ends December 2025
Councilor: David Roush
Distinguished Scientist at Merck Research Labs
Term ends December 2025
Councilor: William Kelly
Professor of Chemical Engineering at Villanova University
Term ends December 2024
Alternate Councilor: Nitya M. Jacob
Executive Director, Biologics Manufacturing Sciences & Technical Operations at Gilead Sciences
Term ends December 2025
Alternate Councilor: Todd Przybycien
Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute
Term ends December 2025
Alternate Councilor & Diversity Chair: Raquel Orozco
Director, CMC Process Development, Abcuro Inc.
Terms ends December 2024
Communications Coordinator: Kelsey McKenna
Principal Scientist, Drug Product Process Development at Amgen
Best of BIOT Chair: Brynn Olden
Associate Director, Viral Vector Process Development at Bristol Myers Squibb
Webmaster: Evan Wells
Senior Scientist, Upstream Bioprocess Development at Johnson and Johnson Innovative Medicine
Peterson Awards Chair: Krunal Mehta
Director, Bioprocess Drug Substance Development and Commercialization at Merck
Membership Chair: Caryn Heldt
Professor at Michigan Technological University
2025 Program Chair: Jonathan Royce
Non-Executive Director, Simris Group
2025 Program Chair: Nicholas Sandoval
Associate Professor of Chemical Engineering at Tulane University
